Tevosol said it named Organ Recovery Systems veteran Ron Mills to be its new CEO.
“Ron knows our technology and our market,” co-founder & CSO Dr. Darren Freed said in prepared remarks. “He brings a wealth of relevant experience to our team and adds a spark of creativity to drive the next exciting stage of our enterprise. Tevosol is fortunate to have Ron Mills at the helm.”
ElectroCore CEO Amato to resign
ElectroCore (NSDQ:ECOR) said last week that CEO Frank Amato is slated to resign once a new chief executive is found, or by Sept. 30 if a replacement isn’t selected by then.
“Under Frank’s leadership, ElectroCore made tremendous progress, including successfully navigating our initial public offering and transitioning to a commercial-stage company with a novel technology targeting three high-value, difficult-to-treat headache indications,” chairwoman Carrie Cox said in prepared remarks. “On behalf of the board, I would like to thank Frank for his contributions as we established a foundation to drive future growth, and I wish him the very best in his future endeavors. We have immediately initiated a search for Frank’s successor, and we are committed to ensuring a seamless transition.”
Dr. Andrew Freiberg joined the Warsaw, Ind.-based company March 1, according to an internal email obtained by MassDevice.com. Freiberg, who is also an associated professor at the Harvard Medical School, is the vice-chair of Mass. General Hospital’s orthopedic surgery dept. and chief of its hip & knee replacement center.
- Amplifon’s Elite Hearing taps new ops & sales VP
- Repro Med Systems names Toomey as growth & innovation VP
- Sciton hires Wong as finance VP and promotes Haaland to global customer service director
- Sanara MedTech (ex-Wound Management Technologies) spikes CEO role
- Golden Meditech chairman & CEO Kam bows out